We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Potential Drug Target To Slow Lymphoma Tumor Growth

News   Apr 08, 2020 | Original story from Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

 
A Potential Drug Target To Slow Lymphoma Tumor Growth

Left, lymph node from a non-lymphoma bearing control mouse. Right, vascular tree in lyph nodes from a lymphoma-bearing mouse. Credit: Rehm, Höpken, Gerhardt Labs, MDC

 
 
Advertisement
 

RELATED ARTICLES

Researchers Cultivate Mini Lungs for SARS-CoV-2 Research

News

A Bochum-based team intends to use organoids derived from stem cells to study the progression of SARS-CoV-2 infection and to identify antiviral substances.

READ MORE

Cells Inside Cells: The Bacteria That Live in Cancer Cells

News

Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers, which found bacteria living inside the cells of all the cancer types – from brain to bone to breast cancer – and even identified unique populations of bacteria residing in each type of cancer.

READ MORE

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE